Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD)

Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism

(2018) Hiroshi Miyazaki et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ?

(2018) Keith E. Eidman et al.   SEMINARS IN DIALYSIS

The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

(2018) Michal L. Melamed et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

(2017) Adeera Levin et al.   LANCET

Vitamin D in Chronic Kidney Disease and Dialysis Patients

(2017) Guillaume Jean et al.   Nutrients

Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease

(2017) Andrea Galassi et al.   Expert Review of Clinical Pharmacology

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)

(2017)   Kidney International Supplements

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease

(2016) Stuart M. Sprague et al.   AMERICAN JOURNAL OF NEPHROLOGY

Pro: Should we correct vitamin D deficiency/insufficiency in chronic kidney disease patients with inactive forms of vitamin D or just treat them with active vitamin D forms?: Table 1.

(2016) David J.A. Goldsmith   NEPHROLOGY DIALYSIS TRANSPLANTATION

Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease

(2016) Rajiv Agarwal et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low

(2015) Jennifer L. Ennis et al.   JOURNAL OF NEPHROLOGY

Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation

(2015) Martin Petkovich et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Effect of active vitamin D on cardiovascular outcomes in predialysis chronic kidney diseases: A systematic review and meta-analysis

(2015) Xiao-Hua Li et al.   NEPHROLOGY

Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease

(2015) Stuart M. Sprague et al.   AMERICAN JOURNAL OF NEPHROLOGY

Effect of Paricalcitol on Left Ventricular Mass and Function in CKD--The OPERA Trial

(2013) A. Y.-M. Wang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease

(2012) Ravi Thadhani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Distribution and regulation of the 25-hydroxyvitamin D3 1α-hydroxylase in human parathyroid glands

(2012) Cynthia S. Ritter et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal Disease

(2011) M. L. Melamed et al.   Clinical Journal of the American Society of Nephrology

Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options

(2011) J. Cunningham et al.   Clinical Journal of the American Society of Nephrology

CYP24A1 and kidney disease

(2011) Martin Petkovich et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease

(2011) Anton Lishmanov et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

(2011) Michael F. Holick et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis

(2011) JESÚS MONTENEGRO et al.   NEPHROLOGY

The vitamin D system: a crosstalk between the heart and kidney

(2010) Mario Cozzolino et al.   EUROPEAN JOURNAL OF HEART FAILURE

Reduced Hepatic Synthesis of Calcidiol in Uremia

(2010) J. Michaud et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis

(2008) Michel Chonchol et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism

(2008) Mario Cozzolino et al.   EXPERT OPINION ON PHARMACOTHERAPY